Bernd Langer

2.0k total citations · 1 hit paper
16 papers, 1.6k citations indexed

About

Bernd Langer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Bernd Langer has authored 16 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Bernd Langer's work include Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Cancer Treatment and Pharmacology (8 papers). Bernd Langer is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Cancer Treatment and Pharmacology (8 papers). Bernd Langer collaborates with scholars based in Germany, Australia and Japan. Bernd Langer's co-authors include Manish A. Shah, Atsushi Ohtsu, Eric Van Cutsem, Yoon‐Koo Kang, Akira Sawaki, Ho Yeong Lim, Sun Young Rha, Jian Wu, Sook Ryun Park and Yasuhide Yamada and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Photochemistry and Photobiology.

In The Last Decade

Bernd Langer

16 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

2011 845 citations Atsushi Ohtsu, Manish A. Shah et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernd Langer Germany	9	1.0k	914	395	376	371	16	1.6k
G. Kurteva United States	10	678 0.7×	686 0.8×	254 0.6×	180 0.5×	199 0.5×	26	1.0k
Federico Buffoli Italy	19	532 0.5×	478 0.5×	618 1.6×	171 0.5×	148 0.4×	45	1.2k
Akira Ooki Japan	20	456 0.4×	617 0.7×	331 0.8×	595 1.6×	97 0.3×	98	1.4k
Hironori Shiozaki Japan	16	494 0.5×	413 0.5×	527 1.3×	728 1.9×	92 0.2×	59	1.5k
Nurten Gündüz United States	12	355 0.4×	760 0.8×	312 0.8×	216 0.6×	54 0.1×	14	1.4k
Swantje Held Germany	17	444 0.4×	920 1.0×	230 0.6×	155 0.4×	35 0.1×	85	1.1k
Helena Melezínková United States	7	624 0.6×	623 0.7×	266 0.7×	192 0.5×	193 0.5×	9	1.0k
Jacqui Rowbottom United Kingdom	10	791 0.8×	1.2k 1.3×	89 0.2×	567 1.5×	35 0.1×	14	1.6k
K Miwa Japan	18	426 0.4×	285 0.3×	276 0.7×	178 0.5×	248 0.7×	44	866
Julia Kitz Germany	22	280 0.3×	564 0.6×	313 0.8×	426 1.1×	77 0.2×	52	1.2k

Countries citing papers authored by Bernd Langer

Since Specialization

Citations

This map shows the geographic impact of Bernd Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Langer more than expected).

Fields of papers citing papers by Bernd Langer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Langer. The network helps show where Bernd Langer may publish in the future.

Co-authorship network of co-authors of Bernd Langer

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Langer. A scholar is included among the top collaborators of Bernd Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Langer. Bernd Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cutsem, Eric Van, Sanne de Haas, Yoon‐Koo Kang, et al.. (2012). Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial. Journal of Clinical Oncology. 30(17). 2119–2127. 358 indexed citations

Ohtsu, Atsushi, Manish A. Shah, Eric Van Cutsem, et al.. (2011). Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study. Journal of Clinical Oncology. 29(30). 3968–3976. 845 indexed citations breakdown →

Ohtsu, Atsushi, Eric Van Cutsem, Laslo Roman, et al.. (2011). Survival analysis by pooling risk factors in AVAGAST: First-line capecitabine and cisplatin plus bevacizumab (bev) or placebo (pla) in patients (pts) with advanced gastric cancer (AGC).. Journal of Clinical Oncology. 29(15_suppl). 4119–4119. 2 indexed citations

Kang, Yoon‐Koo, Atsushi Ohtsu, Laslo Roman, et al.. (2011). 1415 POSTER Blood Plasma VEGFA Analysis in the AVAGAST Randomized Study of First-line Bevacizumab (bev) + Capecitabine/Cisplatin (cape/cis) in Patients (pts) With Advanced Gastric Cancer (AGC). European Journal of Cancer. 47. S173–S174. 3 indexed citations

Kang, Yubin, Atsushi Ohtsu, Eric Van Cutsem, et al.. (2010). AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC).. Journal of Clinical Oncology. 28(18_suppl). LBA4007–LBA4007. 84 indexed citations

Sobrero, Alberto, Stephen P. Ackland, Stephen Clarke, et al.. (2009). Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer. Oncology. 77(2). 113–119. 95 indexed citations

Sobrero, Alberto, Stephen P. Ackland, Stephen Clarke, et al.. (2007). 3060 POSTER Final data from a large phase II trial of first-line bevacizumab plus classic or modified FOLFIRI in metastatic colorectal cancer (CRC). European Journal of Cancer Supplements. 5(4). 254–254. 2 indexed citations

Sobrero, Alberto, Scott Young, Paul N. Mainwaring, et al.. (2007). Phase IV study of first-line bevacizumab plus irinotecan and infusional 5-FU/LV in patients with metastatic colorectal cancer: AVIRI. Journal of Clinical Oncology. 25(18_suppl). 4068–4068. 8 indexed citations

Sobrero, Alberto, Stephen P. Ackland, S. Chiara, et al.. (2006). Efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-FU as first-line treatment for patients with metastatic colorectal cancer. Journal of Clinical Oncology. 24(18_suppl). 3544–3544. 9 indexed citations

10.

Untch, Michael, Steffen Kahlert, Holger Eidtmann, et al.. (2004). Anthracycline and trastuzumab in breast cancer treatment.. PubMed. 18(14 Suppl 14). 59–64. 6 indexed citations

11.

Untch, Michael, Holger Eidtmann, Andreas du Bois, et al.. (2004). Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer. European Journal of Cancer. 40(7). 988–997. 39 indexed citations

12.

Langer, Bernd, M Muscholl, M. Pauschinger, et al.. (2004). Prospective investigation of the significance of cardiac markers, NT-pro Brain Natriuretic Peptide (NT-proBNP) and Troponin T (TnT), in the Hercules study of epirubicin/cyclophosphamide with or without trastuzumab (Herceptin®). European Journal of Cancer Supplements. 2(3). 143–143. 2 indexed citations

13.

Langer, Bernd & Eckard Wellmann. (1990). PHYTOCHROME INDUCTION OF PHOTOREACTIVATING ENZYME IN Phaseolus vulgaris L. SEEDLINGS*. Photochemistry and Photobiology. 52(4). 861–863. 41 indexed citations

14.

Shepherd, Frances A., William K. Evans, Martin E. Blackstein, et al.. (1987). Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma.. Journal of Clinical Oncology. 5(4). 635–640. 36 indexed citations

15.

Ambus, U, et al.. (1978). Randomized trial of chemoimmunotherapy for resectable and non-resectable gastrointestinal cancer.. PubMed. 38. 541–5. 2 indexed citations

16.

Re, Falk, et al.. (1976). Immunostimulation with intraperitoneally administered bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract.. PubMed. 142(3). 363–8. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact